Antimicrobial Stewardship Project Newsletter

Learn About AMR and HAI Surveillance Across Japan and India

We're pleased to announce that our most recent webinar on antimicrobial resistance (AMR) and COVID-19 across Asia is available to view on our YouTube channel. Our presenters, Motoyuki Sugai, DDS, PhD, and Jyoti Joshi, MD, MSc, provide an extraordinary look at AMR, antimicrobial stewardship, antibiotic use and access, and surveillance of drug-resistant and healthcare-associated infections across Japan and India. 

Continuing Education credit is available, and a link to the post-test is provided at the end of the webinar. This activity was supported by an educational grant from BD (Becton, Dickinson, and Company).

View webinar recording

 

New at CIDRAP-ASP

News

AMR in the News

This week, CIDRAP News journalist Chris Dall, MA, reported on funding for a CRISPR-based drug to prevent Escherichia coli infections in cancer patients, inadequate antibiotic therapy for bacterial infections in COVID-19 patients, and more.
Quiz

MDR Organisms in Organic Meat

Test your antimicrobial stewardship knowledge with our June quiz! This month's quiz is based on new US data on the presence of multidrug-resistant organisms in organic versus conventionally raised meat.

COVID-19 and Co-infections

News

COVID-19, Health Security, and AMR Surveillance

On Health Policy Watch, Disha Shetty, MA, reports on conversations happening at the 74th World Health Assembly on the need for the COVID-19 pandemic to inform action against AMR, citing calls for a better understanding of the ties between health and economic crises, along with improved surveillance based on pandemic tools.
Interview

C diff Testing and Infection during the Pandemic

On Contagion, John Parkinson speaks with Armani Hawes, MD, and Payal K. Patel, MD, MPH, about a study they led to examine changes in Clostridioides difficile testing and infection rates during the first wave of the COVID-19 pandemic at a Michigan hospital.
Commentary

COVID-19 and AMR Diagnostics in LMICs

In a post for the British Society for Antimicrobial Chemotherapy's Vanguard Report, Daniel Berman, MIA, and Ruth Neale, MChem, discuss access to AMR diagnostics in low- and middle-income countries, challenging the idea of what makes an intervention or technology "valuable" in the context of what the pandemic has revealed about the limits of centralized approaches to public health.
Meeting Recording

Implications of the Pandemic on Global AMR Surveillance

The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) posted a summary and recording of its second global meeting, highlighting the implications of COVID-19 on global AMR surveillance, the need to strengthen links between surveillance and clinical data, and more.
Perspective

Genomic Sequencing for COVID-19 and Antibiotic Stewardship

Health Education England's Genomic Education Programme highlights issues associated with the high use of antibiotics in COVID-19 patients, also noting that the use of genomic sequencing to track SARS-CoV-2 has the potential to be applied more widely to inform antibiotic stewardship and empirical therapy.

New in the Literature: COVID-19 and Co-infections

The following articles were added to the CIDRAP-ASP COVID-19 and Co-infections bibliography from May 27 to Jun 2, 2021.

Bayram N, Ozsaygılı C, Sav H, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol 2021 (published online May 31)

Bhatt K, Agolli A, Patel MH, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova) 2021 (published online Mar 31)

Foschi C, Zignoli A, Gaibani P, et al. Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: conventional culture vs BioFire FilmArray pneumonia plus panel. J Microbiol Methods 2021 (published online May 29)

Kerguelen C, Merchán A, León J, et al. Effect of COVID-19 pandemic on catheter-related bloodstream infections: control measures should not be relaxed. Infect Control Hosp Epidemiol 2021 (published online May 27)

Manea E, Jipa R, Milea A, et al. Healthcare-associated Clostridioides difficile infection during the COVID-19 pandemic in a tertiary care hospital in Romania. Rom J Intern Med 2021 (published online May 29)

Nehara HR, Puri I, Singhal V, et al. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India. Indian J Med Microbiol 2021 (published online May 26)

Nzawa Soko R, Burke RM, Feasey HRA, et al. Effects of coronavirus disease pandemic on tuberculosis notifications, Malawi. Emerg Infect Dis 2021 (published online May 26)

Puzniak L, Bauer KA, Yu KC, et al. Effect of inadequate empiric antibacterial therapy on hospital outcomes in SARS-CoV-2-positive and -negative US patients with a positive bacterial culture: a multicenter evaluation from March to November 2020. Open Forum Infect Dis 2021 (published online May 26)

Rouze A, Martin-Loeches I, Povoa P, et al. Early bacterial identification among intubated patients with COVID-19 or influenza pneumonia: a European multicenter comparative cohort study. Am J Respir Crit Care Med 2021 (published online May 26)

Sopirala MM. Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change? Curr Opin Infect Dis 2021 (published online May 25)

Tan YX, Wong GW, Tan YH. Superinfection associated with prolonged antibiotic use in non-ventilator associated hospital-acquired pneumonia. Int J Clin Pharm 2021 (published online May 29)

CIDRAP-ASP COVID-19 and Co-infections Resource Hub

Global Policy and Projects

Commentary

Laboratory Equipment Procurement for Susceptibility Testing

The Fleming Fund summarizes a report from the International Procurement Agency on challenges and constraints of delivering laboratory equipment for bacterial infection diagnostics and susceptibility testing across Africa and Asia, recommending early decisions on tax exemptions, better connections with local partners, and support of countries in planning and forecasting for procurement needs and methods.
Communications Campaign

Stories of Drug Resistance

The Global Antibiotic Research and Development Partnership (GARDP) launched "Faces of AMR," a campaign that tells patients' and clinicians' stories of drug resistance and describes the need for new treatments.
Clinical Tools

Australian Decision Support Tools for Common Infections

The Australian Commission on Safety and Quality in Health Care updated three decision support tools that patients and caregivers can use with their healthcare providers to discuss antibiotic use for middle ear infection, acute bronchitis, and sore throat.
Interview

Approaches to Ending Long-Term Antibiotic Use on US Farms

The Pew Charitable Trusts features an interview with David Hyun, MD, and Mark Eichelberg, PhD, about the need for a viable and sustainable approach to end long-term antibiotic use on US farms and feedlots, particularly as it involves tightening US Food and Drug Administration criteria for defining duration limits and dosing strategies.
Webinar Recording

New Clinical Trial Designs for Antimicrobials

The Global Antibiotic Research & Development Partnership posted a recording of a REVIVE webinar on "New clinical trial designs for evaluation of antimicrobial agents," moderated by Thomas Snelling, BMBS, PhD, and featuring presentations from David Paterson, MBBS, and Julie Marsh, PhD, MSc.
Profile

AMR Policy and Communications in Oman

The World Health Organization describes the work of Amal Saif Al-Maani, MD, to campaign for efforts that prevent and manage AMR at Oman's national and local levels, along with advocating for the global importance of rational antibiotic use in meeting the Sustainable Development Goals.

Want More CIDRAP-ASP?

  • Keep up with the latest by following @CIDRAP_ASP on Twitter. We post daily threads of what we've added to our COVID-19 and Co-infections Resource Hub.

  • We recently published a literature review on innovative approaches to tuberculosis surveillance, decentralization of care, and post-pandemic resilience across China, Italy, Peru, and South Africa, which you can find on our ASP Research page.

  • We update our bibliographies every day with new resources on antimicrobial stewardship interventions, diagnostics, policy, AMR surveillance, and more. 

  • We co-produced a podcast series—"Superbugs and You"—with the Antimicrobial Resistance Fighter Coalition that features stories of resilience and innovation from patients, clinicians, and researchers experiencing and finding solutions to drug-resistant infections. You can listen to the series online or on your podcast app of choice.

  • We update our diagnostics and surveillance resource hubs weekly. Learn more about antibiograms, laboratory capacity in low- and middle-income countries, AMR surveillance across the One Health spectrum, and tools to implement AMR and antibiotic use data collection in diverse settings.

  • Are you looking for an online course, a video or infographic, a webinar recording, or another tool to educate yourself or others about AMR and antimicrobial stewardship? Check out our vast collection of educational multimedia, which is updated monthly with new resources.

CIDRAP-ASP Website

Facebook
LinkedIn
Twitter
RSS Feeds

Contact Us

Center for Infectious Disease Research and Policy
Office of the Vice President for Research, University of Minnesota, Minneapolis, MN

Copyright © 2021 Regents of the University of MN
Office of the Vice President for Research, University of MN

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.